International Publisher of Science, Technology and Medicine

 

Ulrich Mahlknecht

Ulrich Mahlknecht

Ulrich Mahlknecht, MD, PhD
Division of Immunotherapy and Gene Therapy
Saarland University, Germany

 

Biography

Dr. Ulrich Mahlknecht studied medicine at the University of Bochum, the University of Birmingham, the Paris-Sud 11 University and the University of Tübingen, where he received his medical doctorate in 1995. Dr. Ulrich Mahlknecht received his postgraduate medical training in internal medicine at the University of Freiburg in Freiburg im Breisgau. From 2004 until 2007 he was an associate professor at the University Hospital Heidelberg where he was the head of the acute leukemias and myelodysplastic syndromes task force. Ulrich Mahlknecht was the founder of the Heidelberg excellence center for myelodysplastic syndromes. In 2007 Ulrich Mahlknecht became a full professor of medicine at the Saarland University, where he is currently head of the Division of Immunotherapy and Gene Therapy within the Department of Internal Medicine.

Research Interest

Molecular Medicine, Therapeutics, Translational Research, Internal medicine, Oncology

 

Publications

Editors & Editorial Board Members
none:  Mol Med Ther 2012, 1:1
doi: #
#
Abstract  |   Full-text  |   PDF  |  
Editors & Editorial Board Members
none:  Mol Med Ther 2012, 1:2
doi:
Abstract  |   Full-text  |   PDF  |  
Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research
Editorial:  Mol Med Ther 2012, 1:1
doi: 10.4172/2324-8769.1000e101
Aamir Shahzad, Randall J Cohrs, Adong Shen and Cornelia Lass-Flörl
Abstract  |   Full-text  |   PDF  |  
Performance of Commercial Interferon-γ Release Assays for Screening Latent Tuberculosis Infection: A Meta-Analysis
Research Article:  Mol Med Ther 2012, 1:2
doi: 10.4172/2324-8769.1000103
Lin Sun, Qingqin Yin, Jianling Tian, Qing Miao, Fang Xu, Jing Xiao, Chen Shen, Weiwei Jiao, Cornelia Lass-Flörl, Aamir Shahzad and Adong Shen
Abstract  |   Full-text  |   PDF  |  
Parkinson’s Disease and Type-2 Diabetes: Methylglyoxal may be a Common Causal Agent; Carnosine could be Protective
Review Article:  Mol Med Ther 2012, 1:2
doi: 10.4172/2324-8769.1000104
Alan R. Hipkiss
Abstract  |   Full-text  |   PDF  |  
Prolyl Hydroxylases in fight or flight
Editorial:  Mol Med Ther 2012, 1:1
doi: 10.4172/2324-8769.1000e102
Anne-Theres Henze, Rodrigo Leite de Oliveira and Massimiliano Mazzone
Abstract  |   Full-text  |   PDF  |  
Genome-Scale Mapping of MicroRNA Signatures in Human Embryonic Stem Cell Neurogenesis
Research Article:  Mol Med Ther 2012, 1:2
doi: 10.4172/2324-8769.1000105
Xuejun H. Parsons, James F. Parsons and Dennis A. Moore
Abstract  |   Full-text  |   PDF  |  
Regulation of Coronary Vasomotor Function by Reactive Oxygen Species
Review Article:  Mol Med Ther 2012, 1:1
doi: 10.4172/2324-8769.1000101
Lih Kuo, Naris Thengchaisri and Travis W. Hein
Abstract  |   Full-text  |   PDF  |  
Novel Combinatorial Therapeutic Targeting of PAI-1(SERPINE1) Gene Expression in Alzheimer’s Disease
Short Communication:  Mol Med Ther 2012, 1:2
doi: 10.4172/2324-8769.1000106
Stacie M. Kutz, Craig E. Higgins and Paul J. Higgins
Abstract  |   Full-text  |   PDF  |  
Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease
Short Communication:  Mol Med Ther 2012, 1:1
doi: 10.4172/2324-8769.1000102
Tessa M. Simone and Paul J. Higgins
Abstract  |   Full-text  |   PDF  |  
 
izmit escort sex geschichten escort bayan porno sikis adult porno pornolar
anakara escort
test